289 related articles for article (PubMed ID: 23899692)
1. Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.
Kim HG; Tan L; Weisberg EL; Liu F; Canning P; Choi HG; Ezell SA; Wu H; Zhao Z; Wang J; Mandinova A; Griffin JD; Bullock AN; Liu Q; Lee SW; Gray NS
ACS Chem Biol; 2013 Oct; 8(10):2145-50. PubMed ID: 23899692
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a broad spectrum antiproliferative agent with selectivity for DDR1 kinase: cell line-based assay, kinase panel, molecular docking, and toxicity studies.
Elkamhawy A; Park JE; Cho NC; Sim T; Pae AN; Roh EJ
J Enzyme Inhib Med Chem; 2016; 31(1):158-66. PubMed ID: 25807298
[TBL] [Abstract][Full Text] [Related]
3. Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors.
Canning P; Tan L; Chu K; Lee SW; Gray NS; Bullock AN
J Mol Biol; 2014 Jun; 426(13):2457-70. PubMed ID: 24768818
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 4-amino-1H-pyrazolo[3,4-d]pyrimidin derivatives as novel discoidin domain receptor 1 (DDR1) inhibitors.
Dong R; Zhou X; Wang M; Li W; Zhang JY; Zheng X; Tang KX; Sun LP
Bioorg Med Chem; 2021 Jan; 29():115876. PubMed ID: 33246255
[TBL] [Abstract][Full Text] [Related]
5. Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery.
Kothiwale S; Borza CM; Lowe EW; Pozzi A; Meiler J
Drug Discov Today; 2015 Feb; 20(2):255-61. PubMed ID: 25284748
[TBL] [Abstract][Full Text] [Related]
6. A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present).
Guo J; Zhang Z; Ding K
Expert Opin Ther Pat; 2020 May; 30(5):341-350. PubMed ID: 32077340
[No Abstract] [Full Text] [Related]
7. Discovery and optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as novel selective and orally bioavailable discoidin domain receptor 1 (DDR1) inhibitors.
Gao M; Duan L; Luo J; Zhang L; Lu X; Zhang Y; Zhang Z; Tu Z; Xu Y; Ren X; Ding K
J Med Chem; 2013 Apr; 56(8):3281-95. PubMed ID: 23521020
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel dasatinib analogues as potent DDR1 and DDR2 kinase inhibitors.
Liu L; Hussain M; Luo J; Duan A; Chen C; Tu Z; Zhang J
Chem Biol Drug Des; 2017 Mar; 89(3):420-427. PubMed ID: 27589335
[TBL] [Abstract][Full Text] [Related]
9. Discovery of
Liu L; Zhao L; Yang L; Chai M; Liu Z; Ma N; Wang Y; Wu Q; Guo J; Zhou F; Huang W; Ren X; Wang J; Ding M; Wang Z; Ding K
J Med Chem; 2024 May; 67(10):8043-8059. PubMed ID: 38730324
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Pyrazolo[3,4-
Tan X; Li C; Yang R; Zhao S; Li F; Li X; Chen L; Wan X; Liu X; Yang T; Tong X; Xu T; Cui R; Jiang H; Zhang S; Liu H; Zheng M
J Med Chem; 2022 Jan; 65(1):103-119. PubMed ID: 34821145
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel discoidin domain receptor 1 (DDR1) inhibitors using E-pharmacophore modeling, structure-based virtual screening, molecular dynamics simulation and MM-GBSA approaches.
Nada H; Lee K; Gotina L; Pae AN; Elkamhawy A
Comput Biol Med; 2022 Mar; 142():105217. PubMed ID: 35032738
[TBL] [Abstract][Full Text] [Related]
12. Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors.
Murray CW; Berdini V; Buck IM; Carr ME; Cleasby A; Coyle JE; Curry JE; Day JE; Day PJ; Hearn K; Iqbal A; Lee LY; Martins V; Mortenson PN; Munck JM; Page LW; Patel S; Roomans S; Smith K; Tamanini E; Saxty G
ACS Med Chem Lett; 2015 Jul; 6(7):798-803. PubMed ID: 26191369
[TBL] [Abstract][Full Text] [Related]
13. Research progress of DDR1 inhibitors in the treatment of multiple human diseases.
Liu M; Zhang J; Li X; Wang Y
Eur J Med Chem; 2024 Mar; 268():116291. PubMed ID: 38452728
[TBL] [Abstract][Full Text] [Related]
14. Design and Synthesis of DDR1 Inhibitors with a Desired Pharmacophore Using Deep Generative Models.
Yoshimori A; Asawa Y; Kawasaki E; Tasaka T; Matsuda S; Sekikawa T; Tanabe S; Neya M; Natsugari H; Kanai C
ChemMedChem; 2021 Mar; 16(6):955-958. PubMed ID: 33289306
[TBL] [Abstract][Full Text] [Related]
15. Small molecule discoidin domain receptor kinase inhibitors and potential medical applications.
Li Y; Lu X; Ren X; Ding K
J Med Chem; 2015 Apr; 58(8):3287-301. PubMed ID: 25569119
[TBL] [Abstract][Full Text] [Related]
16. DDR1 and DDR2 physical interaction leads to signaling interconnection but with possible distinct functions.
Croissant C; Tuariihionoa A; Bacou M; Souleyreau W; Sala M; Henriet E; Bikfalvi A; Saltel F; Auguste P
Cell Adh Migr; 2018; 12(4):324-334. PubMed ID: 29616590
[TBL] [Abstract][Full Text] [Related]
17. Effect of Hypoxia on DDR1 Expression in Pituitary Adenomas.
Li S; Zhang Z; Xue J; Guo X; Liang S; Liu A
Med Sci Monit; 2015 Aug; 21():2433-8. PubMed ID: 26286316
[TBL] [Abstract][Full Text] [Related]
18. Collagen type I selectively activates ectodomain shedding of the discoidin domain receptor 1: involvement of Src tyrosine kinase.
Slack BE; Siniaia MS; Blusztajn JK
J Cell Biochem; 2006 Jun; 98(3):672-84. PubMed ID: 16440311
[TBL] [Abstract][Full Text] [Related]
19. Genetic and pharmacological inhibition of PDK1 in cancer cells: characterization of a selective allosteric kinase inhibitor.
Nagashima K; Shumway SD; Sathyanarayanan S; Chen AH; Dolinski B; Xu Y; Keilhack H; Nguyen T; Wiznerowicz M; Li L; Lutterbach BA; Chi A; Paweletz C; Allison T; Yan Y; Munshi SK; Klippel A; Kraus M; Bobkova EV; Deshmukh S; Xu Z; Mueller U; Szewczak AA; Pan BS; Richon V; Pollock R; Blume-Jensen P; Northrup A; Andersen JN
J Biol Chem; 2011 Feb; 286(8):6433-48. PubMed ID: 21118801
[TBL] [Abstract][Full Text] [Related]
20. The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer.
Elkamhawy A; Lu Q; Nada H; Woo J; Quan G; Lee K
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
